Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis

Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis

(2022) A. Libánská et al.   JOURNAL OF CONTROLLED RELEASE

Nanomedicine Strategies for Anti‐Inflammatory Treatment of Noninfectious Arthritis

(2021) Long Chen et al.   Advanced Healthcare Materials

Applicability and implementation of the collagen‑induced arthritis mouse model, including protocols (Review)

(2021) Jing Luan et al.   Experimental and Therapeutic Medicine

Structural optimization of HPMA copolymer-based dexamethasone prodrug for improved treatment of inflammatory arthritis

(2020) Zhenshan Jia et al.   JOURNAL OF CONTROLLED RELEASE

Advanced nanomedicines for the treatment of inflammatory diseases

(2020) Romain Brusini et al.   ADVANCED DRUG DELIVERY REVIEWS

Nanomedicine for the Treatment of Rheumatoid Arthritis

(2020) Moonkyoung Jeong et al.   MOLECULAR PHARMACEUTICS

Development of a Janus Kinase Inhibitor Prodrug for the Treatment of Rheumatoid Arthritis

(2018) Xin Wei et al.   MOLECULAR PHARMACEUTICS

Rheumatoid arthritis

(2018) Josef S. Smolen et al.   Nature Reviews Disease Primers

N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production

(2018) Eva Koziolová et al.   BIOMACROMOLECULES

Advanced nanomedicine for rheumatoid arthritis treatment: focus on active targeting

(2017) Minglei Chen et al.   Expert Opinion on Drug Delivery

Pharmacokinetic and Biodistribution Studies of HPMA Copolymer Conjugates in an Aseptic Implant Loosening Mouse Model

(2017) Xin Wei et al.   MOLECULAR PHARMACEUTICS

Targeted delivery of low-dose dexamethasone using PCL–PEG micelles for effective treatment of rheumatoid arthritis

(2016) Qin Wang et al.   JOURNAL OF CONTROLLED RELEASE

Glucocorticoids and Rheumatoid Arthritis

(2016) Joana Fonseca Ferreira et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

The Evaluation of the Therapeutic Efficacy and Side Effects of a Macromolecular Dexamethasone Prodrug in the Collagen-Induced Arthritis Mouse Model

(2015) Lingdong Quan et al.   PHARMACEUTICAL RESEARCH

Nanomedicines for Inflammatory Arthritis: Head-to-Head Comparison of Glucocorticoid-Containing Polymers, Micelles, and Liposomes

(2013) Lingdong Quan et al.   ACS Nano

Development of macromolecular prodrug for rheumatoid arthritis

(2012) Fang Yuan et al.   ADVANCED DRUG DELIVERY REVIEWS

N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation

(2010) Petr Chytil et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Pharmacokinetic and Biodistribution Studies ofN-(2-Hydroxypropyl)methacrylamide Copolymer-Dexamethasone Conjugates in Adjuvant-Induced Arthritis Rat Model

(2010) Ling-dong Quan et al.   MOLECULAR PHARMACEUTICS

Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy

(2010) Ling-dong Quan et al.   ARTHRITIS RESEARCH & THERAPY

Stereogradient Polymers Formed by Controlled/Living Radical Polymerization of Bulky Methacrylate Monomers

(2009) Kenji Ishitake et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION